Disopyramide in hypertrophic cardiomyopathy I. Hemodynamic assessment after intravenous administration
- 1 December 1988
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 62 (17) , 1248-1251
- https://doi.org/10.1016/0002-9149(88)90268-8
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A reviewProgress in Cardiovascular Diseases, 1985
- Muscular Subaortic StenosisNew England Journal of Medicine, 1982
- The cardiac effects of d- and l-disopyramide in normal subjects: a noninvasive study.Circulation, 1982
- Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. I. Hemodynamic effects.Circulation, 1979
- Haemodynamic effects of disopyramide in patients after open-heart surgery.Heart, 1979
- Adverse hemodynamic effects of intravenous disopyramide compared with quinidine in conscious dogs.Circulation, 1979
- Calciumantagonistische Therapie bei hypertroph-obstruktiver KardiomyopathieDeutsche Medizinische Wochenschrift (1946), 1976
- Muscular Subaortic StenosisCirculation, 1968
- Beta-adrenergic Blockade in Hypertrophic Obstructive CardiomyopathyBMJ, 1966
- Hemodynamic alterations in idiopathic hypertrophic subaortic stenosis induced by sympathomimetic drugs∗The American Journal of Cardiology, 1962